Ataxia-Telangiectasia Latest Advances

Find the Latest Research About Ataxia-Telangiectasia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4333 publications

Recent Advances in Therapy for the Neurodegenerative Disorder Ataxia-Telangiectasia.

Recent Advances in Therapy for the Neurodegenerative Disorder Ataxia-Telangiectasia.

Journal: International journal of molecular sciences
Published: July 20, 2026

A Phase 2 Study of Berzosertib in Combination with Carboplatin compared to Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer.

A Phase 2 Study of Berzosertib in Combination with Carboplatin compared to Docetaxel with Carboplatin in Metastatic Castration-Resistant Prostate Cancer.

Journal: Cancer research communications
Published: July 20, 2026

WWOX contributes to DNA damage, but not somatic instability in Huntington's disease.

WWOX contributes to DNA damage, but not somatic instability in Huntington's disease.

Journal: bioRxiv : the preprint server for biology
Published: July 03, 2026

Inhibition of ATM, ATR and DNA-PK radiosensitises 3D uveal melanoma models to X-rays and proton beam therapy.

Inhibition of ATM, ATR and DNA-PK radiosensitises 3D uveal melanoma models to X-rays and proton beam therapy.

Journal: Frontiers in oncology
Published: June 27, 2026

A 4-year-old male presenting with frequent falls, clumsily rising from seated positions, but a normal creatine kinase.

A 4-year-old male presenting with frequent falls, clumsily rising from seated positions, but a normal creatine kinase.

Journal: Clinica chimica acta; international journal of clinical chemistry
Published: June 23, 2026

Fulminant disseminated histoplasmosis in a pediatric patient with ataxia-telangiectasia and autoimmune hepatitis: A diagnostic and therapeutic challenge.

Fulminant disseminated histoplasmosis in a pediatric patient with ataxia-telangiectasia and autoimmune hepatitis: A diagnostic and therapeutic challenge.

Journal: IDCases
Published: June 18, 2026

Clinical, Immunological Findings, and Outcomes of Children with Ataxia-Telangiectasia: A Single Center Experience.

Clinical, Immunological Findings, and Outcomes of Children with Ataxia-Telangiectasia: A Single Center Experience.

Journal: Pediatric allergy, immunology, and pulmonology
Published: June 17, 2026

TRIM29 is Critical for Bladder Cancer Progression and Modulates the Tumor-Immune Niche.

TRIM29 is Critical for Bladder Cancer Progression and Modulates the Tumor-Immune Niche.

Journal: Research square
Published: June 04, 2026

Clinical Characteristics of IgE Deficiency Among Patients with Primary Immunodeficiencies: Findings from the USIDNET Registry.

Clinical Characteristics of IgE Deficiency Among Patients with Primary Immunodeficiencies: Findings from the USIDNET Registry.

Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: June 01, 2026

Exploiting the Weak Link: Ataxia-Telangiectasia Mutated Dysfunction in Oesophagogastric Tumours.

Exploiting the Weak Link: Ataxia-Telangiectasia Mutated Dysfunction in Oesophagogastric Tumours.

Journal: Critical reviews in oncology/hematology
Published: May 21, 2026

Identification of dual-targeting PROTACs for ataxia telangiectasia and RAD3-related and aurora kinase A as chemo-sensitizers for leukemia cells.

Identification of dual-targeting PROTACs for ataxia telangiectasia and RAD3-related and aurora kinase A as chemo-sensitizers for leukemia cells.

Journal: European journal of medicinal chemistry
Published: May 20, 2026

USP1 inhibition promotes RAD18-dependent PCNA degradation and BRCA1 synthetic lethality.

USP1 inhibition promotes RAD18-dependent PCNA degradation and BRCA1 synthetic lethality.

Journal: bioRxiv : the preprint server for biology
Published: May 18, 2026
Showing 1-12 of 4,333

Last Updated: 09/26/2026